|
1
|
Ostrom QT, Gittleman H, Xu J, Kromer C,
Wolinsky Y, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical
report: Primary brain and other central nervous system tumors
diagnosed in the United States in 2009-2013. Neuro Oncol. 18(Suppl
5): v1–v75. 2016. View Article : Google Scholar
|
|
2
|
Conti A, Gulì C, La Torre D, Tomasello C,
Angileri FF and Aguennouz M: Role of inflammation and oxidative
stress mediators in gliomas. Cancers (Basel). 2:693–712. 2010.
View Article : Google Scholar
|
|
3
|
Ham SW, Jeon HY, Jin X, Kim EJ, Kim JK,
Shin YJ, Lee Y, Kim SH, Lee SY, Seo S, et al: TP53 gain-of-function
mutation promotes inflammation in glioblastoma. Cell Death Differ.
26:409–425. 2019. View Article : Google Scholar :
|
|
4
|
Philip M, Rowley DA and Schreiber H:
Inflammation as a tumor promoter in cancer induction. Semin Cancer
Biol. 14:433–439. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Aggarwal BB, Vijayalekshmi RV and Sung B:
Targeting inflammatory pathways for prevention and therapy of
cancer: Short-term friend, long-term foe. Clin Cancer Res.
15:425–430. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Grivennikov SI and Karin M: Inflammation
and oncogenesis: A vicious connection. Curr Opin Genet Dev.
20:65–71. 2010. View Article : Google Scholar :
|
|
7
|
Samadi AK, Bilsland A, Georgakilas AG,
Amedei A, Amin A, Bishayee A, Azmi AS, Lokeshwar BL, Grue B, Panis
C, et al: A multi-targeted approach to suppress tumor-promoting
inflammation. Semin Cancer Biol. 35:S151–S184. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Colotta F, Allavena P, Sica A, Garlanda C
and Mantovani A: Cancer-related inflammation, the seventh hallmark
of cancer: Links to genetic instability. Carcinogenesis.
30:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hussain SP, Hofseth LJ and Harris CC:
Radical causes of cancer. Nat Rev Cancer. 3:276–285. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schetter AJ, Heegaard NH and Harris CC:
Inflammation and cancer: Interweaving microRNA, free radical,
cytokine and p53 pathways. Carcinogenesis. 31:37–49. 2010.
View Article : Google Scholar :
|
|
12
|
Kembro JM, Cortassa S, Lloyd D, Sollott SJ
and Aon MA: Mitochondrial chaotic dynamics: Redox-energetic
behavior at the edge of stability. Sci Rep. 8:154222018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Blajszczak C and Bonini MG: Mitochondria
targeting by environmental stressors: Implications for redox
cellular signaling. Toxicology. 391:84–89. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Altieri DC: Mitochondria on the move:
Emerging paradigms of organelle trafficking in tumour plasticity
and metastasis. Br J Cancer. 117:301–305. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhai K, Chang L, Zhang Q, Liu B and Wu Y:
Mitochondrial C150T polymorphism increases the risk of cervical
cancer and HPV infection. Mitochondrion. 11:559–563. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Canter JA, Kallianpur AR, Parl FF and
Millikan RC: Mitochondrial DNA G10398A polymorphism and invasive
breast cancer in African-American women. Cancer Res. 65:8028–8033.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Permuth-Wey J, Chen YA, Tsai YY, Chen Z,
Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, et
al: Inherited vari-ants in mitochondrial biogenesis genes may
influence epithelial ovarian cancer risk. Cancer Epidemiol
Biomarkers Prev. 20:1131–1145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Katsetos CD, Anni H and Draber P:
Mitochondrial dysfunction in gliomas. Semin Pediatr Neurol.
20:216–227. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Arismendi-Morillo GJ and
Castellano-Ramirez AV: Ultrastructural mitochondrial pathology in
human astrocytic tumors: Potentials implications protherapeutics
strategies. J Electron Microsc (Tokyo). 57:33–39. 2008. View Article : Google Scholar
|
|
20
|
Guntuku L, Naidu VG and Yerra VG:
Mitochondrial dysfunction in gliomas: Pharmacotherapeutic potential
of natural compounds. Curr Neuropharmacol. 14:567–583. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Strickland M and Stoll EA: Metabolic
reprogramming in glioma. Front Cell Dev Biol. 5:432017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Waitkus MS, Diplas BH and Yan H:
Isocitrate dehydrogenase mutations in gliomas. Neuro Oncol.
18:16–26. 2016. View Article : Google Scholar
|
|
23
|
Warburg O: On the origin of cancer cells.
Science. 123:309–314. 1956. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Modica-Napolitano JS and Weissig V:
Treatment strategies that enhance the efficacy and selectivity of
mitochondria-targeted anticancer agents. Int J Mol Sci.
16:17394–17421. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Vyas S, Zaganjor E and Haigis MC:
Mitochondria and cancer. Cell. 166:555–566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mancias JD and Kimmelman AC: Mechanisms of
selective autophagy in normal physiology and cancer. J Mol Biol.
428:1659–1680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun H, Zhang M, Cheng K, Li P, Han S, Li
R, Su M, Zeng W, Liu J, Guo J, et al: Resistance of glioma cells to
nutrient-deprived microenvironment can be enhanced by
CD133-mediated autophagy. Oncotarget. 7:76238–76249. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Isakovic AM, Dulovic M, Markovic I,
Kravic-Stevovic T, Bumbasirevic V, Trajkovic V and Isakovic A:
Autophagy suppression sensitizes glioma cells to IMP dehydrogenase
inhibition-induced apoptotic death. Exp Cell Res. 350:32–40. 2017.
View Article : Google Scholar
|
|
29
|
Louis DN, Perry A, Reifenberger G, von
Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD,
Kleihues P and Ellison DW: The 2016 world health organization
classification of tumors of the central nervous system: A summary.
Acta Neuropathol. 131:803–820. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xue H, Yuan G, Guo X, Liu Q, Zhang J, Gao
X, Guo X, Xu S, Li T, Shao Q, et al: A novel tumor-promoting
mechanism of IL6 and the therapeutic efficacy of tocilizumab:
Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma
via the p-STAT3-MIR155-3p-CREBRF pathway. Autophagy. 12:1129–1152.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jia L, Liang T, Yu X, Ma C and Zhang S:
MGARP regulates mouse neocortical development via mitochondrial
positioning. Mol Neurobiol. 49:1293–1308. 2014. View Article : Google Scholar
|
|
32
|
Weber DJ, Allette YM, Wilkes DS and White
FA: The HMGB1-RAGE inflammatory pathway: Implications for brain
injury-induced pulmonary dysfunction. Antioxid Redox Signal.
23:1316–1328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bai Y and Attardi G: The mtDNA-encoded ND6
subunit of mitochondrial NADH dehydrogenase is essential for the
assembly of the membrane arm and the respiratory function of the
enzyme. EMBO J. 17:4848–4858. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang H, Luo J, Tian W, Yan W, Ge S, Zhang
Y and Sun W: γ-tocotrienol inhibits oxidative phosphorylation and
triggers apoptosis by inhibiting mitochondrial complex I subunit
NDUFB8 and complex II subunit SDHB. Toxicology. 417:42–53. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Kim SE, Mori R, Komatsu T, Chiba T,
Hayashi H, Park S, Sugawa MD, Dencher NA and Shimokawa I:
Upregulation of cytochrome c oxidase subunit 6b1 (Cox6b1) and
formation of mitochondrial supercomplexes: Implication of Cox6b1 in
the effect of calorie restriction. Age (Dordr). 37:97872015.
View Article : Google Scholar
|
|
36
|
Motori E, Puyal J, Toni N, Ghanem A,
Angeloni C, Malaguti M, Cantelli-Forti G, Berninger B, Conzelmann
KK, Götz M, et al: Inflammation-induced alteration of astrocyte
mitochondrial dynamics requires autophagy for mitochondrial network
maintenance. Cell Metab. 18:844–859. 2013.PubMed/NCBI
|
|
37
|
Kageyama Y, Hoshijima M, Seo K, Bedja D,
Sysa-Shah P, Andrabi SA, Chen W, Höke A, Dawson VL, Dawson TM, et
al: Parkin-independent mitophagy requires Drp1 and maintains the
integrity of mammalian heart and brain. EMBO J. 33:2798–2813.
2014.PubMed/NCBI
|
|
38
|
Williams JA and Ding WX: Mechanisms,
pathophysiological roles and methods for analyzing mitophagy-recent
insights. Biol Chem. 399:147–178. 2018.
|
|
39
|
Dan Dunn J, Alvarez LA, Zhang X and
Soldati T: Reactive oxygen species and mitochondria: A nexus of
cellular homeostasis. Redox Biol. 6:472–485. 2015.PubMed/NCBI
|
|
40
|
Chio IIC and Tuveson DA: ROS in cancer:
The burning question. Trends Mol Med. 23:411–429. 2017.PubMed/NCBI
|
|
41
|
Shadel GS and Horvath TL: Mitochondrial
ROS signaling in organismal homeostasis. Cell. 163:560–569. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sullivan LB and Chandel NS: Mitochondrial
reactive oxygen species and cancer. Cancer Metab. 2:172014.
View Article : Google Scholar
|
|
43
|
Jin L, Li D, Alesi GN, Fan J, Kang HB, Lu
Z, Boggon TJ, Jin P, Yi H, Wright ER, et al: Glutamate
dehydrogenase 1 signals through antioxidant glutathione peroxidase
1 to regulate redox homeostasis and tumor growth. Cancer Cell.
27:257–270. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
DeNicola GM, Karreth FA, Humpton TJ,
Gopinathan A, Wei C, Frese K, Mangal D, Yu KH, Yeo CJ, Calhoun ES,
et al: Oncogene-induced Nrf2 transcription promotes ROS
detoxification and tumorigenesis. Nature. 475:106–109. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Gaude E and Frezza C: Defects in
mitochondrial metabolism and cancer. Cancer Metab. 2:102014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Anderson NM, Mucka P, Kern JG and Feng H:
The emerging role and targetability of the TCA cycle in cancer
metabolism. Protein Cell. 9:216–237. 2018. View Article : Google Scholar :
|
|
47
|
Chen L, Liu T, Zhou J, Wang Y, Wang X, Di
W and Zhang S: Citrate synthase expression affects tumor phenotype
and drug resistance in human ovarian carcinoma. PLoS One.
9:e1157082014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Schlichtholz B, Turyn J, Goyke E,
Biernacki M, Jaskiewicz K, Sledzinski Z and Swierczynski J:
Enhanced citrate synthase activity in human pancreatic cancer.
Pancreas. 30:99–104. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Lin CC, Cheng TL, Tsai WH, Tsai HJ, Hu KH,
Chang HC, Yeh CW, Chen YC, Liao CC and Chang WT: Loss of the
respiratory enzyme citrate synthase directly links the Warburg
effect to tumor malignancy. Sci Rep. 2:7852012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sinkler CA, Kalpage H, Shay J, Lee I,
Malek MH, Grossman LI and Hüttemann M: Tissue- and
condition-specific isoforms of mammalian cytochrome c oxidase
subunits: From function to human disease. Oxid Med Cell Longev.
2017:15340562017. View Article : Google Scholar :
|
|
51
|
Zhang W, Wang Y, Wan J, Zhang P and Pei F:
COX6B1 relieves hypoxia/reoxygenation injury of neonatal rat
cardiomyocytes by regulating mitochondrial function. Biotechnol
Lett. 41:59–68. 2019. View Article : Google Scholar :
|
|
52
|
Um JH and Yun J: Emerging role of
mitophagy in human diseases and physiology. BMB Rep. 50:299–307.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kulikov AV, Luchkina EA, Gogvadze V and
Zhivotovsky B: Mitophagy: Link to cancer development and therapy.
Biochem Biophys Res Commun. 482:432–439. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Ney PA: Mitochondrial autophagy: Origins,
significance, and role of BNIP3 and NIX. Biochim Biophys Acta.
1853:2775–2783. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Arnoult D, Rismanchi N, Grodet A, Roberts
RG, Seeburg DP, Estaquier J, Sheng M and Blackstone C:
Bax/Bak-dependent release of DDP/TIMM8a promotes Drp1-mediated
mitochondrial fission and mitoptosis during programmed cell death.
Curr Biol. 15:2112–2118. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Dengjel J and Abeliovich H: Roles of
mitophagy in cellular physiology and development. Cell Tissue Res.
367:95–109. 2017. View Article : Google Scholar
|
|
57
|
Eiyama A and Okamoto K:
PINK1/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell
Biol. 33:95–101. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Kornmann B: Quality control in
mitochondria: Use it, break it, fix it, trash it. F1000Prime Rep.
6:152014. View
Article : Google Scholar : PubMed/NCBI
|
|
59
|
Deng P and Haynes CM: Mitochondrial
dysfunction in cancer: Potential roles of ATF5 and the
mitochondrial UPR. Semin Cancer Biol. 47:43–49. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ding WX, Li M, Biazik JM, Morgan DG, Guo
F, Ni HM, Goheen M, Eskelinen EL and Yin XM: Electron microscopic
analysis of a spherical mitochondrial structure. J Biol Chem.
287:42373–42378. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Ding WX, Guo FL, Ni HM, Bockus A, Manley
S, Stolz DB, Eskelinen EL, Jaeschke H and Yin XM: Parkin and
mitofusins reciprocally regulate mitophagy and mitochondrial
spheroid formation. J Biol Chem. 287:42379–42388. 2012.PubMed/NCBI
|
|
62
|
Findlay AS, Carter RN, Starbuck B, McKie
L, Nováková K, Budd PS, Keighren MA, Marsh JA, Cross SH, Simon MM,
et al: Mouse Idh3a mutations cause retinal degeneration and reduced
mitochondrial function. Dis Model Mech. 11:2018.
|
